MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
LONDON and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc NASDAQ:MGTX, a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, 2026, and provided a corporate update.“We are plea…